This inventor holds 6 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Chang Gung University, Other. Active years: 2016-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Taoyuan Couny, TW (2017)
- Tao-Yuan, TW (2016 - 2022)
Company Filing History:
3 out of 185 
3 out of 834,570 Years Active: 2016-2022
Title: **Ching-Ping Tseng: Innovations in Coagulation Treatment**
Introduction
Ching-Ping Tseng is a renowned inventor based in Taoyuan, Taiwan, recognized for his significant contributions to the field of medical innovations. With a remarkable portfolio of six patents, his work focuses primarily on advancing treatments for thrombotic conditions.
Latest Patents
Two of Ching-Ping Tseng’s latest patents showcase his innovative approaches to coagulation factor therapies. The first patent, titled "Aptamers for targeting coagulation factor XIII and uses thereof," presents an aptamer that specifically targets coagulation factor XIII (FXIII). This aptamer serves as a vital bio-tool for labeling thrombi and for delivering drugs directly to thrombotic areas. The disclosure details methods for treating diseases related to FXIII, particularly thrombosis.
His second patent, "Method of using niclosamide derivatives," explores the use of niclosamide derivatives in creating medicaments designed to suppress platelet aggregation and prevent thrombosis-related diseases. These derivatives inhibit the production of thromboxane A2, leading to effective prevention of thrombotic conditions.
Career Highlights
Throughout his career, Ching-Ping Tseng has worked at Chang Gung University, where his research and development efforts have led to practical applications in medicine. His expertise in the area of thrombotic treatments has positioned him as a leading figure in the field.
Collaborations
Ching-Ping Tseng has collaborated with colleagues such as Pei-Wen Hsieh and Yao-Wen Chang, contributing to the collective goal of advancing healthcare through innovative solutions. These collaborations have furthered the development of effective treatments for thrombosis, demonstrating the power of teamwork in scientific research.
Conclusion
Ching-Ping Tseng's impact in the realm of medical innovations is profound, particularly regarding the treatment of thrombotic diseases. His patents not only highlight his creativity and expertise but also pave the way for new therapeutic strategies, potentially saving countless lives. As he continues to develop groundbreaking solutions, the medical community eagerly anticipates his future contributions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile